Ella Negrou

Title: Ella Negrou: Innovator in Antibody Development

Introduction

Ella Negrou is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target phosphorylated Rab proteins. Her work has implications for understanding various cellular processes and diseases.

Latest Patents

Ella holds a patent for "Phospho-Rab antibodies, assays and methods of use thereof." This patent includes antibodies that specifically bind to phosphorylated Rab proteins, including human Rab10 and Rab8a. The monoclonal antibodies she developed recognize specific epitopes, which are crucial for detecting LRRK2 and Rab proteins. Ella's innovative approach enhances the tools available for research in cellular signaling and disease mechanisms. She has 1 patent to her name.

Career Highlights

Ella Negrou has established herself as a key figure in her field through her work at Denali Therapeutics Inc. Her research focuses on the intersection of antibody development and cellular biology. She has demonstrated a commitment to advancing scientific knowledge and improving therapeutic strategies.

Collaborations

Ella collaborates with notable colleagues, including Jason C Dugas and Xiang Wang. These partnerships enhance her research efforts and contribute to the innovative environment at Denali Therapeutics Inc.

Conclusion

Ella Negrou is a trailblazer in the development of targeted antibodies, with a focus on phosphorylated Rab proteins. Her contributions to biotechnology are paving the way for advancements in understanding cellular processes and potential therapeutic applications.